Wire Stories

eCloudvalley Demonstrates its Cloud Expertise at CIO Innovation Forum

HONG KONG--(BUSINESS WIRE)--eCloudvalley Digital Technology (ECV), AWS Premier Tier Services Partner, has assisted more than 450 Hong Kong enterprises in…

3 years ago

Standard Chartered completes industry-first pilot of Trade Financing Validation Service provided by MonetaGo over SWIFT

SINGAPORE--(BUSINESS WIRE)--Standard Chartered has successfully completed an industry-first pilot testing of the Trade Financing Validation Service provided by MonetaGo over…

3 years ago

24 Tech Startups from Asian Countries & Regions to Compete for the 11th AEA 2022 Innovation Award

AEA 2022: October 26th (Wed.) to 27th (Thu.) Online Social Business Session Based on Dr. Muhammad Yunus� Seven Principles is…

3 years ago

The Asahi Glass Foundation: Survey on the Awareness of Environmental Issues Among the General Public (in Japan and 24 other countries)

Climate change was rated as the top issue TOKYO--(BUSINESS WIRE)--The Asahi Glass Foundation, chaired by Takuya Shimamura, conducted an online…

3 years ago

The time on the Clock has turned back for two consecutive years since 2021, striking 9:35 in 2022. It was…

3 years ago

idolplus, Media Platform for K-pop Entertainers, Launched Globally in Six Languages

idolplus, a Korean media platform for K-pop entertainers, launched globally This web service released in six languages, including English, Chinese…

3 years ago

Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA�(pembrolizumab) demonstrates anti-tumor benefit in…

3 years ago

BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--$bgne #beigene--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused…

3 years ago

DALLAS, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an…

3 years ago

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer

Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled…

3 years ago